Delivery Order SPE2DB24D1107-SPE2DB25FZEL3
Award Date
2/18/25
Potential Completion Date
2/19/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,811.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of May 9, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of...
This federal contract award, valued at $1,833.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a vaccine product, with a completion date of February 13, 2023. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $6,790.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 1,440 UNIT/ML syringes, a vaccine product, and has an ultimate completion date of January 10, 2023. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen, the prime contractor, has a...
This federal contract award, valued at $1,725.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of HAVRIX 1,440 UNIT/ML SYRINGEML, a medical vaccine product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,905.50, is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML. It is a firm fixed-price delivery order that runs through February 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,215.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of December 11, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML. The $1,304.07 firm fixed-price delivery order contract has a completion date of June 18, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to various federal government agencies, particularly within military and veterans' healthcare...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,118.16 delivery order contract is for the supply of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 18, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,707.31, is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML medical supplies. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 3, 2025. The award is not associated with a set-aside designation, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.22 firm fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a vaccine product. The contract has an ultimate completion date of January 31, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...